26 November 2021>: Articles
A New Potential Strategy for Acute Non-Alcoholic Steatohepatitis (NASH)
Unusual or unexpected effect of treatment
Anupamjeet Kaur Sekhon B* , Aniruddha Gollapalli E , Dharamjeet Kaur E , Bryan Janssen D , Mark L. Stevens E , Fernando Valerio A , Miguel A. Sierra-Hoffman EDOI: 10.12659/AJCR.932961
Am J Case Rep 2021; 22:e932961
Figure 2. Liver function test (LFT) values in a graph showing rapidly increasing LFTs in the acute phase of non-alcoholic steatohepatitis and decreasing after PCSK9 inhibitor treatment.